pcn poster

Posters

Treatment Experiences of Individuals With Schizophrenia: Findings From an Online Survey

Background: This study examined experiences of patients living with schizophrenia with a history of oral antipsychotic medication (OAM) use.

Julia Carpenter-Conlin , MSW;

Leona Bessonova , PhD;

Jakob Bjorner , MD, PhD;

Dawn Velligan , PhD;

Michael Doane , PhD;

Martha Sajatovic , MD;

Stephen Maher , PhD;

Asia Sikora Kessler , PhD;

11/22/2019

Descriptive Patterns Emerging From Initial Antidepressant Treatment Episodes in Patients with Treatment-Resistant Depression

Background: TRD leads to excess healthcare costs and burden of illness. Early patterns of antidepressant use may signify patients at high-risk for TRD. Methods: Eligible patients with ma...

John Verbanac , PhD;

Wing Chow , PharmD, MPH;

Jacqueline Pesa , PhD, MPH;

Charles Ruetsch , PhD;

Joshua Liberman , PhD;

Tigwa Davis , PhD;

Sara Heverly-Fitt , PhD;

11/22/2019

Post Marketing Rate of Seizures During Transcranial Magnetic Stimulation (TMS) Treatment With NeuroStar® Advanced Therapy Appears to Be Lower Than Previously Estimated

Transcranial magnetic stimulation (TMS) delivered with the NeuroStar® Advanced Therapy System is an effective acute treatment for patients with major depressive disorder (MDD). With TMS, ...

Karen Heart , BS, MBA;

Philip Janicak , MD;

Bridget McGugan , PharmD, MBA;

11/22/2019

National Trends in the Prevalence of Major Depressive Disorder With Suicidal Ideation Among Adults Using National Survey on Drug Use and Health Data

Introduction: Although depression is a known risk factor for suicide, little is known about how the prevalence of co-occurring major depressive disorder (MDD) and suicidal ideation/behavi...

Ella Daly , MB, BCh, BAO;

Kun Wang , PhD;

Harsh Kuvadia ;

John J. Sheehan , PhD, MBA, RPh;

Jennifer Voelker , MS, PharmD;

Jacqueline Pesa , PhD, MPH;

Nancy Connolly , MPH;

Ayush Srivastava , BS ;

11/22/2019

The Efficacy of Lumateperone 42 mg in the Treatment of Schizophrenia: A Pooled Analysis of Randomized Controlled Trials

Introduction: Lumateperone (lumateperone tosylate, ITI-007) is in late-phase clinical development for schizophrenia. Lumateperone has a unique mechanism of action that simultaneously modu...

Robert Davis , PhD;

Kimberly Vanover , PhD;

Andrew Satlin , MD;

Carol Tamminga , MD;

Sharon Mates , PhD;

Tobie Escher , PhD;

11/22/2019

Combinatorial Pharmacogenomic Testing Improves Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized, Controlled Trial

Objectives: The GUIDED trial demonstrated that combinatorial pharmacogenomic (PGx) testing significantly improved the rate of response (p=0.007) and remission (p=0.005) and approached sig...

John Greden , MD;

Anthony Rothschild , MD;

Michael Thase , MD;

Boadie Dunlop , MD;

Richard Shelton , MD;

Charles Conway , MD;

Lisa Brown , PhD;

Jennie Depatie , PhD;

Brent Forester , MD, MSc;

James Li , MS, PhD;

Matthew Macaluso , DO;

Krystal Brown , PhD;

Michael J. Crescenz ;

Michael Jablonski , PhD;

Charles DeBattista , MD;

Sagar Parikh , MD;

11/22/2019

Dasotraline for Treatment of Adults With Binge-Eating Disorder: Effect on Binge-related Obsessions and Compulsions

Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated efficacy in the treatment of binge-eating disorder (BED). We now repor...

Leslie Citrome , MD;

Robert Goldman , PhD;

Ling Deng , PhD;

Todd Grinnell , BA;

Andrei Pikalov , MD, PhD;

Joyce Tsai , PhD;

11/22/2019

US Mental Health Resource Utilization in Major Depressive Disorder With Suicidal Ideation

Introduction: Major depressive disorder (MDD) and suicidal ideation/behavior, both incur substantial mental health resource utilization (MHRU) burden, yet little is known of the burden of...

Ella Daly , MB, BCh, BAO;

Kun Wang , PhD;

Harsh Kuvadia ;

John J. Sheehan , PhD, MBA, RPh;

Jennifer Voelker , MS, PharmD;

Jacqueline Pesa , PhD, MPH;

Nancy Connolly , MPH;

11/22/2019

A Post Hoc Analysis Evaluating the Impact of a Reduction in Psychosis on the Severity of Agitation and Aggression in Patients With Alzheimer’s Disease

This post hoc analysis evaluates whether improvement in hallucinations and delusions during pimavanserin (PIM) treatment among Alzheimer’s dementia (AD) patients with psychosis leads to i...

Bruce Coate , MPH;

Michael Guskey , PharmD;

Srdjan Stankovic , MD, MSPH;

Clive Ballard , MBChB;

11/22/2019

A Retrospective Cohort Study of Suicidality Among Patients With Binge Eating Disorder

Individuals diagnosed with binge eating disorder (BED) are at higher risk of suicidality than those not diagnosed with BED. This study estimated the incidence (per 1000 person-years) of s...

William Spalding , MS;

Monica Bertoia , MPH, PhD;

Mei Lu , MS;

Akin Akinwonmi , MD;

John Seeger , PharmD, DrPH, FISPE;

Cynthia Bulik , PhD, FAED;

11/22/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products